共 50 条
- [21] PHASE II TRIAL OF SEQUENTIAL N-PHOSPHONACETYL-L-ASPARTATE (PALA), THYMIDINE (TDR), AND 5-FLUOROURACIL (5-FU) IN ADVANCED COLORECTAL-CANCER PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 182 - 182
- [23] ALTERATIONS IN PRPP AND URIDINE NUCLEOTIDE POOLS IN THE LEWIS LUNG-CARCINOMA BY N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 268 - 268
- [24] ROLE OF ENDOCYTOSIS AND LYSOSOMAL PH IN UPTAKE OF N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) AND ITS INHIBITION OF PYRIMIDINE SYNTHESIS MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (01): : 80 - 80
- [28] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THYMIDINE (TDR), 5-FLUOROURACIL (5FU) AND N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) IN COMBINATION PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 358 - 358
- [30] PHARMACOLOGIC DISPOSITION OF N-(PHOSPHONACETHYL)-L-ASPARTATE (PALA) IN MAN PHARMACOLOGIST, 1979, 21 (03): : 233 - 233